Filter
8717
Filtered Results: 8717
Text search:
drugs
Featured
Recommendations
718
New Publications
2183
Language
Document type
No document type
5131
Studies & Reports
1280
Guidelines
1071
Manuals
376
Strategic & Response Plan
249
Fact sheets
230
Training Material
133
Situation Updates
74
Infographics
59
Resource Platforms
44
Brochures
39
Online Courses
16
Videos
11
Dashboards/Maps
2
App
2
Countries / Regions
India
488
Global
288
Kenya
251
South Africa
198
Ethiopia
178
Nepal
172
Uganda
166
Western and Central Europe
165
Nigeria
161
Sierra Leone
153
Tanzania
130
Zambia
124
Liberia
123
Malawi
121
Latin America and the Carribbean
120
Rwanda
112
Bangladesh
110
Ghana
107
Ukraine
106
Africa
104
Myanmar / Burma
102
Eastern Europe
87
Indonesia
74
Philippines
71
Namibia
71
Russia
69
Zimbabwe
64
Congo, Democratic Republic of
62
Asia
52
Senegal
51
South–East Asia Region
51
Syria
48
Cambodia
48
Lesotho
47
Germany
47
Mozambique
46
Brazil
43
Burkina Faso
42
Botswana
39
South Sudan
38
Colombia
36
Haiti
36
Venezuela
33
West and Central Africa
31
Eswatini/ Swaziland
31
East and Southern Africa
30
Middle East and North Africa
28
Cameroon
24
Guinea
23
Tajikistan
22
Chile
22
Paraguay
22
Eastern Europe and Central Asia
20
Argentina
20
Benin
19
Peru
19
USA
17
Yemen
17
Albania
16
Afghanistan
16
Sudan
16
Vietnam
15
Moldova
15
Pakistan
15
Bolivia
14
Madagascar
14
China
12
Georgia
12
Central African Republic
12
Thailand
11
Armenia
11
Western Pacific Region
11
Lebanon
11
Somalia
11
North Macedonia
10
Laos
10
North America
9
Ecuador
9
Mexico
8
Mali
8
El Salvador
7
Jordan
7
United Kingdom
7
Sri Lanka
7
Angola
7
Palestine
6
Libya
6
Iraq
6
Serbia
5
Turkey
5
Guinea-Bissau
5
Spain
5
Southern Africa
5
Papua New Guinea
5
Romania
5
Bhutan
5
Iran
4
Fiji
4
Estonia
4
Kyrgyzstan
4
Niger
4
Uzbekistan
4
Burundi
4
Saudi Arabia
4
Jamaica
4
Côte d’Ivoire / Ivory Coast
4
Egypt
4
Poland
4
Switzerland
3
Timor Leste/ East Timor
3
Kazakhstan
3
Morocco
3
Hungary
3
Uruguay
3
Belarus
3
Greece
3
Chad
3
Gambia
2
Canada
2
Singapore
2
Mongolia
2
Qatar
2
Lithuania
2
Ireland
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Djibouti
2
Honduras
2
North Korea
1
Australia
1
Congo-Brazzaville
1
Malaysia
1
Austria
1
Bulgaria
1
Italy
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3380
Clinical Guidelines
729
Public Health
391
Women & Child Health
344
Key Resources
266
Capacity Building
142
Pharmacy & Technologies
90
Annual Report MEDBOX
2
Toolboxes
HIV
916
Mental Health
877
TB
758
COVID-19
499
NTDs
368
AMR
364
Pharmacy
270
NCDs
203
Caregiver
199
Ebola & Marburg
168
Rapid Response
152
Refugee
145
Conflict
128
Disability
119
Planetary Health
119
Global Health Education
86
Health Financing Toolbox
78
Natural Hazards
57
Zika
37
Cholera
35
Polio
29
Specific Hazards
26
Social Ethics
24
Malaria
15
South Sudan
2
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Информационный бюллетень Июнь 2020 г.
Уязвимые группы населения в контексте ответных мер в отношении COVID-19
Vulnerable populations during COVID-19 response - Drug users
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
Alcohol can be a source of enjoyment. However, it can also be a drug or a source of addiction, with negative consequences for your health and the people around you.
Accessed: 14.03.2019
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
SOP explaining how to complete a stock card in order to track the number (quantity) of drugs in the stores area.
Last revised 2015.
Original Word document on:
http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Stock%20Control%20Card_SOP.doc
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
